Want to see RCUS full AI Analyst Report?
Compare Arcus Biosciences (RCUS) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| RCUSArcus Biosciences | $18.19 | $2.58B | -4.63 | -9.91% | Moderate Buy | RCUS | ||||
| XNCRXencor | $29.82 | $2.22B | -13.74 | 111.04% | Strong Buy | RCUS vs XNCR | ||||
| CRSPCrispr Therapeutics AG | $51.42 | $4.97B | -10.80 | -15.84% | Moderate Buy | RCUS vs CRSP | ||||
| LEGNLegend Biotech | $21.63 | $4.19B | -43.26 | -32.93% | Moderate Buy | RCUS vs LEGN | ||||
| NRIXNurix Therapeutics | $26.80 | $2.93B | 10.68 | 109.70% | Strong Buy | RCUS vs NRIX | ||||
| IMCRImmunocore Holdings | $30.49 | $1.57B | -169.11 | -5.28% | Moderate Buy | RCUS vs IMCR |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RCUS | Arcus Biosciences | 18.19 | -2.16 | -10.61% | |
| XNCR | Xencor | 29.82 | 15.88 | 113.92% | |
| CRSP | Crispr Therapeutics AG | 51.42 | -10.55 | -17.02% | |
| LEGN | Legend Biotech | 21.63 | -10.50 | -32.68% | |
| NRIX | Nurix Therapeutics | 26.80 | 14.18 | 112.36% | |
| IMCR | Immunocore Holdings | 30.49 | -1.89 | -5.84% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts